1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics in North America Countries, June 2016 (p3)

Pharmaceutical Analysis & Statistics in North America Countries, June 2016 (p3)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

61-90 of about 5 500 reports

Purchase Reports From Reputable Market Research Publishers

Insulin Delivery Devices - Global Trends, Estimates and Forecasts, 2014-2021

Insulin Delivery Devices - Global Trends, Estimates and Forecasts, 2014-2021

  • $ 4 240
  • Industry report
  • June 2016
  • by Axis Research Mind

Global Market Watch: The Invasive Devices market is expected to reach US$10.4 billion by 2016 primarily supported by the segments Syringes, Pens, Pumps and Other. Globally, Syringes and Pumps togethe ...

  • Industries : Therapy, Pharmaceutical, Medical Device
  • Countries : United States, World
The World Market for Companion Diagnostics

The World Market for Companion Diagnostics

  • $ 4 200
  • Industry report
  • June 2016
  • by Kalorama Information

The World Market for Companion Diagnostics covers the world market for companion diagnostic and personalized medicine diagnostics. Market analysis in the report includes the following: - World IVD Companion ...

  • Industries : Genomics
  • Countries : United States
Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016

Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016

  • $ 4 000
  • Industry report
  • July 2016
  • by Global Data

Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016" ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Industrial Equipment, Machine Tool and Equipment, Drug Delivery
  • Countries : United States
Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016

  • $ 4 000
  • Industry report
  • July 2016
  • by Global Data

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016" ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Asia Pacific Veterinary Healthcare Market - Mordor Intelligence

Asia Pacific Veterinary Healthcare Market - Mordor Intelligence

  • $ 3 850
  • Industry report
  • May 2016
  • by Mordor Intelligence LLP

The Asia Pacific veterinary healthcare market, estimated at USD 5.4 billion in 2015, is set to reach $10.6 billion by 2020, with a CAGR of 14.33% over the forecast period. Veterinary healthcare market ...

  • Industries : Veterinary Healthcare, Healthcare, Therapy
  • Countries : Asia, World, United States
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 6 (Protein Phosphatase 1 ...

  • Industries : Cancer, Pathology, Therapy, Pharmaceutical
  • Countries : United States
C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - ...

  • Industries : Cancer, Pathology, Therapy, Biological Therapy
  • Countries : United States
Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016

Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Proprotein ...

  • Industries : Therapy, Chronic Disease, Pharmaceutical, Pathology
  • Countries : United States, World
Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Granulocyte ...

  • Industries : Biological Therapy, Therapy, Biotechnology, Cancer, Pathology, Pharmaceutical
  • Countries : United States
Growth/Differentiation Factor 8 (Myostatin or GDF-8) - Pipeline Review, H1 2016

Growth/Differentiation Factor 8 (Myostatin or GDF-8) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Growth/Differentiation Factor 8 (Myostatin or GDF-8) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Growth/Differentiation Factor 8 (Myostatin or GDF-8) - Pipeline Review, H1 2016’, ...

  • Industries : Pathology, Therapy
  • Countries : United States
Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016

Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) ...

  • Industries : In Vitro Diagnostics
  • Countries : United States
Catenin Beta-1 (Beta Catenin or CTNNB1) - Pipeline Review, H1 2016

Catenin Beta-1 (Beta Catenin or CTNNB1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Catenin Beta-1 (Beta Catenin or CTNNB1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Catenin Beta-1 (Beta Catenin or CTNNB1) - Pipeline Review, H1 2016’, provides in depth analysis ...

  • Industries : Cancer, Therapy
  • Countries : World, United States
Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2016

Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2016 ...

  • Industries : Therapy, Cancer, Pathology
  • Countries : United States
CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Biopharmaceutical, Biological Therapy, Therapy, Biotechnology, Pathology, Cancer
  • Countries : United States
Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, H1 2016

Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, ...

  • Industries : Therapy, Cancer, Pathology, Pharmaceutical
  • Countries : United States
Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) - Pipeline Review, H1 2016

Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Matrix Metalloproteinase ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : World, United States
Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016

Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016’, provides in depth analysis on Gamma Secretase ...

  • Industries : Pathology, Mental Health, Pharmaceutical, Therapy
  • Countries : United States
Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016

Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016 Summary Global Markets ...

  • Industries : Pathology, Cancer, Therapy, Pharmaceutical
  • Countries : United States
20s Proteasome - Pipeline Review, H1 2016

20s Proteasome - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

20s Proteasome - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘20s Proteasome - Pipeline Review, H1 2016’, provides in depth analysis on 20s Proteasome targeted pipeline therapeutics. ...

  • Industries : Therapy
  • Countries : World, United States
Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1-Associated Factor 1 or EC 3.5.1.98) - Pipeline Review, H1 2016

Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1-Associated Factor 1 or EC 3.5.1.98) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1-Associated Factor 1 or EC 3.5.1.98) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 2 (Transcriptional ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016

Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 ...

  • Industries : Cancer, Therapy, Pathology, Biotechnology, Oncology, Biopharmaceutical, Pharmaceutical
  • Countries : United States
Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) - Pipeline Review, H1 2016

Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) - Pipeline Review, ...

  • Industries : Therapy, Pathology, Drug Discovery and Development
  • Countries : World, United States
P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent Granule-External Membrane Protein or CD62P) - Pipeline Review, H1 2016

P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent Granule-External Membrane Protein or CD62P) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent Granule-External Membrane Protein or CD62P) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘P-Selectin (Granule ...

  • Industries : Therapy, Pharmaceutical, Pathology, Biopharmaceutical
  • Countries : World, United States
Apolipoprotein E (ApoE) - Pipeline Review, H1 2016

Apolipoprotein E (ApoE) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Apolipoprotein E (ApoE) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Apolipoprotein E (ApoE) - Pipeline Review, H1 2016’, provides in depth analysis on Apolipoprotein E (ApoE) targeted ...

  • Industries : Chronic Disease, Pathology, Therapy
  • Countries : United States
C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016

C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 5 (C-C CKR-5 ...

  • Industries : Therapy, Biological Therapy, Pharmaceutical
  • Countries : United States
Complement C5 (C3 And PZP-Like Alpha-2-Macroglobulin Domain-Containing Protein 4) - Pipeline Review, H1 2016

Complement C5 (C3 And PZP-Like Alpha-2-Macroglobulin Domain-Containing Protein 4) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Complement C5 (C3 And PZP-Like Alpha-2-Macroglobulin Domain-Containing Protein 4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Complement C5 (C3 And PZP-Like Alpha-2-Macroglobulin ...

  • Industries : Biopharmaceutical, Therapy, Pharmaceutical, Biotechnology
  • Countries : World, United States, Europe
Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2016

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) ...

  • Industries : Biological Therapy, Pathology, Biotechnology, Therapy
  • Countries : United States
Protein Kinase C Epsilon Type (nPKC-Epsilon or EC 2.7.11.13) - Pipeline Review, H1 2016

Protein Kinase C Epsilon Type (nPKC-Epsilon or EC 2.7.11.13) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Protein Kinase C Epsilon Type (nPKC-Epsilon or EC 2.7.11.13) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Protein Kinase C Epsilon Type (nPKC-Epsilon or EC 2.7.11.13) - Pipeline Review, ...

  • Industries : Biopharmaceutical, Therapy, Mental Health, Pharmaceutical, Drug Discovery and Development
  • Countries : United States, World
Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016

Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Tumor Necrosis Factor Recepto ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.